Are Germline Mosaic TSC1/2 Variants Present in Controls? Implications for Diagnosis - 18/12/23
, Jianxiang Liao, MD, PhD b, ⁎, 1
, Michael S. Hildebrand, PhD a, f, h, ⁎, 1 
Keywords : Exome sequencing, Variant interpretation, Mosaicism, Recurrence risk, Tuberous sclerosis complex
| Author contributions: Z.Y., S.L., X.Z., M.W., V.W.Z., S.F.B., I.E.S., J.L., and M.S.H made substantial contributions to the conception or design of the work. Z.Y., S.L., X.Z., M.W., X.G., L.S., J.W., J.D., Y.Y., L.L., L.C., D.C., Z.H., V.W.Z., S.F.B., I.E.S., J.L., and M.S.H. contributed to acquisition, analysis, or interpretation of data for the work. Z.Y., S.L., X.Z., M.W., X.G., L.S., J.W., J.D., Y.Y., L.L., L.C., D.C., Z.H., V.W.Z., S.F.B., I.E.S., J.L., and M.S.H. contributed to drafting the work or revising it critically for important intellectual content. Z.Y., S.L., X.Z., M.W., X.G., L.S., J.W., J.D., Y.Y., L.L., L.C., D.C., Z.H., V.W.Z., S.F.B., I.E.S., J.L., and M.S.H. contributed to final approval of the version to be published. Z.Y., S.L., X.Z., M.W., X.G., L.S., J.W., J.D., Y.Y., L.L., L.C., D.C., Z.H., V.W.Z., S.F.B., I.E.S., J.L., and M.S.H. agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Z.Y., S.L., X.Z., I.E.S., J.L., and M.S.H confirm that they had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. |
|
| Data availability statement: Data available on reasonable request due to privacy/ethical restrictions. |
Vol 150
P. 37-39 - janvier 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
